FDA Inspection 1191426 — Ecron Acunova Limited
The FDA completed an inspection of Ecron Acunova Limited on Nov 10, 2022 in Chennai. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Nov 10, 2022
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Chennai (India)
Additional details
Clinical BA/BE